Inositol pyrophosphate kinases in health and disease
FEBS Letters · 2026
DOI: 10.1002/1873-3468.70192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, 2026. Verfasst von Changchang Xing und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China. Hauptthemen laut MEDLINE: Phosphotransferases (Phosphate Group Acceptor), Inositol Phosphates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Inositol phosphates (InsPs) are intracellular signaling molecules that are essential for life. Inositol pyrophosphates, a subset of inositol phosphates, are the end products of inositol phosphate metabolism. In mammalian cells, up to 90% of inositol pyrophosphates are 5‐diphosphoinositol 1,2,3,4,6‐pentakisphosphate (5PP‐InsP 5 ), which is generated by inositol hexakisphosphate kinases (IP6Ks). 5PP‐InsP 5 can be further phosphorylated by diphosphoinositol pentakisphosphate kinases (PPIP5Ks) to generate 1,5‐bisdiphosphoinositol 2,3,4,6‐tetrakisphosphate (InsP 8 ). Unlike freely diffusible molecules, 5PP‐InsP 5 and InsP 8 act locally at the sites where they are synthesized. Thus, individual IP6K and PPIP5K enzymes perform specific functions. Preclinical and clinical studies suggest that these molecules contribute to early life development, but mediate age‐related diseases beyond adulthood. In this review, we summarize the functions and mechanisms of action of every individual IP6K and PPIP5K in both physiological processes and diseases and discuss the potential applications of these inositol pyrophosphate kinases as druggable targets for disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China.
- Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China.
- Department of Hypertension, Peking University People's Hospital, Beijing, China.
- Department of Nuclear Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China.
ORCID-Profile: Chenglai Fu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Xing, C., Wang, C., Chen, Y., Cheng, W., Jiang, Z., Chen, A. F., & Fu, C. (2026). Inositol pyrophosphate kinases in health and disease. FEBS Letters. https://doi.org/10.1002/1873-3468.70192
Vancouver
Xing C, Wang C, Chen Y, Cheng W, Jiang Z, Chen AF, et al. Inositol pyrophosphate kinases in health and disease. FEBS Letters. 2026. doi:10.1002/1873-3468.70192
BibTeX
@article{Xing2026,
author = {Xing, Changchang and Wang, Chao and Chen, Yuanyuan and Cheng, Weiwei and Jiang, Zhaolei and Chen, Alex F and Fu, Chenglai},
title = {Inositol pyrophosphate kinases in health and disease},
journal = {FEBS Letters},
year = {2026},
doi = {10.1002/1873-3468.70192}
}
EUVIMED